FDA Inspection
Paul Harmatz, M.D.Paul Harmatz, M.D. – FDA Inspection, Oct 2, 2013
Record Details
This FDA Inspection record concerns Paul Harmatz, M.D., with an inspection on October 2, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Paul Harmatz, M.D.
- Inspection Date
- October 2, 2013
- Product Type
- Drugs
View Company Profile
ID · 78e94531-6e35-4dc4-9117-54234f582b4a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 849987
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.60FD-1572, protocol compliance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Paul Harmatz, M.D.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| August 21, 2025 | NAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
| November 5, 2020 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| October 16, 2020 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| June 16, 2017 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Paul Harmatz, M.D.
- FDA Inspection 1280024 - 2025-08-21
- FDA Inspection 1131540 - 2020-11-05
- FDA Inspection 1131717 - 2020-10-16
- FDA Inspection 1014482 - 2017-06-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.